CoQ10 to reduce inflammation after heart surgery
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether CoQ10 (a natural nutrient) can lessen harmful inflammation and help protect organs after cardiovascular surgery. If you qualify, you may receive CoQ10 during the surgical period and be followed for how your body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (man or woman).
- You are scheduled to have cardiovascular (heart or blood vessel) surgery.
- You agree to take part in the study and sign the consent form.
- If you are pregnant, you cannot join this study.
- If you plan to become pregnant during the study, you cannot join.
- You may need to have fewer than 2 signs of metabolic syndrome to be eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine that lowers cholesterol can also reduce inflammation and protect organs during and after heart bypass surgery. If you are having bypass surgery soon, this study may help improve your recovery.
This trial tests whether taking a low dose of colchicine, an anti-inflammatory medicine, after heart bypass surgery can help keep the new blood vessels open and working well. It may help reduce the chance of the bypass grafts failing.
This trial tests if taking coenzyme Q10 before and after thoracoscopic lung surgery can reduce pain. It may help you recover more comfortably.
This trial tests whether combining two natural supplements (CoQ10 and glutathione) can protect your kidneys during heart bypass surgery. It may help prevent acute kidney injury, a common complication after these procedures.
This study tests whether the drug colchicine can reduce inflammation and protect organs during and after planned heart surgery. It may help people recover better.
This study tests whether a low-cost, anti-inflammatory drug called colchicine can reduce heart complications after major non-heart surgery. If you have heart or blood vessel risk factors and are scheduled for a major operation, this trial may help protect your heart.
Hear when a new Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.